Current treatment options: impact of cytogenetics on the course of myelodysplasia (Q36883685)

16 August 2017

1 reference

title

Current treatment options: impact of cytogenetics on the course of myelodysplasia (English)

1 reference

16 August 2017

1 reference

Naomi Galili

1

1 reference

16 August 2017

Jan Cerny

series ordinal

2

1 reference

16 August 2017

Azra Raza

series ordinal

3

1 reference

16 August 2017

publication date

1 April 2007

1 reference

Current Treatment Options in Oncology

16 August 2017

published in

1 reference

16 August 2017

volume

8

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

117-128

1 reference

Proposals for the classification of the myelodysplastic syndromes

16 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-007-0017-1

Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia

21 January 2018

1 reference

12 December 2020

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

1 reference

12 December 2020

Molecular analysis of the 5q- chromosome

1 reference

12 December 2020

Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia

1 reference

12 December 2020

Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta

1 reference

12 December 2020

Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries

1 reference

12 December 2020

Immunotherapeutic and antitumour potential of thalidomide analogues

1 reference

12 December 2020

Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome

1 reference

12 December 2020

Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome

1 reference

12 December 2020

Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients.

1 reference

12 December 2020

Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study

1 reference

12 December 2020

Treatment of hypereosinophilic syndrome with imatinib mesilate

1 reference

12 December 2020

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

1 reference

12 December 2020

Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate

1 reference

12 December 2020

De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features?

1 reference

12 December 2020

Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution

1 reference

12 December 2020

Transient donor cell-derived myelodysplastic syndrome with monosomy 7 after unrelated cord blood transplantation

1 reference

12 December 2020

Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia

1 reference

12 December 2020

Risk factor analysis in myelodysplastic syndrome patients with del(20q): prognosis revisited.

1 reference

12 December 2020

Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage

1 reference

12 December 2020

Oncogenic transcription factors in the human acute leukemias

1 reference

12 December 2020

Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia

1 reference

12 December 2020

Molecular classification and pathogenesis of eosinophilic disorders: 2005 update

1 reference

12 December 2020

Prognostic significance of del(20q) in patients with hematological malignancies

1 reference

12 December 2020

Atypical chronic myelomonocytic leukemia with eosinophilia and translocation (5;12). A new association

1 reference

12 December 2020

The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997

1 reference

12 December 2020

Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate

1 reference

12 December 2020

Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci

1 reference

12 December 2020

Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2).

1 reference

12 December 2020

Prediction of 18-month survival in patients with primary myelodysplastic syndrome. A regression model and scoring system based on the combination of chromosome findings and the Bournemouth score.

1 reference

12 December 2020

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

1 reference

12 December 2020

Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome

1 reference

12 December 2020

Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Español de Citogenética Hematológica

1 reference

12 December 2020

Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia.

1 reference

12 December 2020

Cellular distribution of platelet-derived growth factor, transforming growth factor-beta, basic fibroblast growth factor, and their receptors in normal bone marrow

1 reference

12 December 2020

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

1 reference

12 December 2020

Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases

1 reference

12 December 2020

Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders

1 reference

12 December 2020

Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7.

1 reference

12 December 2020

Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia

1 reference

12 December 2020

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 reference

12 December 2020

Efficacy of lenalidomide in myelodysplastic syndromes

1 reference

12 December 2020

CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins

1 reference

12 December 2020

Diagnostic and prognostic significance of cytogenetics in adult primary myelodysplastic syndromes

1 reference

12 December 2020

Diagnosis, classification, and cytogenetics of myelodysplastic syndromes.

1 reference

12 December 2020

Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21).

1 reference

12 December 2020

A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome

1 reference

12 December 2020

The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways

1 reference

12 December 2020

TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13).

1 reference

12 December 2020

Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies

1 reference

12 December 2020

10.1007/S11864-007-0017-1

Identifiers

DOI

1 reference

16 August 2017

1 reference